Form 8-K - Current report:
SEC Accession No. 0001140361-25-000708
Filing Date
2025-01-10
Accepted
2025-01-10 07:23:21
Documents
19
Period of Report
2025-01-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20040004_8k.htm   iXBRL 8-K 47221
2 EXHIBIT 10.1 ef20040004_ex10-1.htm EX-10.1 185324
3 EXHIBIT 10.2 ef20040004_ex10-2.htm EX-10.2 173744
4 EXHIBIT 99.1 ef20040004_ex99-1.htm EX-99.1 19012
8 image01.jpg GRAPHIC 1867
9 image02.jpg GRAPHIC 2298
10 image00003.jpg GRAPHIC 2577
  Complete submission text file 0001140361-25-000708.txt   660824

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atai-20250107.xsd EX-101.SCH 3974
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20250107_lab.xml EX-101.LAB 22691
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20250107_pre.xml EX-101.PRE 16547
21 EXTRACTED XBRL INSTANCE DOCUMENT ef20040004_8k_htm.xml XML 4213
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 25520405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)